Related Experiment Videos
[Delayed autotransfusion associated with the cell-saver method in cardiovascular surgery. Values, methods, initial
F Jault1, I Gandjbakhch, P Debat
1Service de chirurgie cardio-vasculaire, hôpital de la Pitie, Paris, France.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 1, 1989
Summary
Deferred autotransfusion using the Cell-Saver system effectively minimizes the need for homologous blood transfusions in cardiac surgery. This technique is well-tolerated and reduces risks associated with external blood products.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Biomedical Engineering
Context:
- Intraoperative blood salvage using the Cell-Saver system is employed to reduce homologous blood transfusions.
- This method has been utilized in cardiac surgery since 1987.
- Established contraindications include unstable angina, severe cardiac failure, and low hemoglobin levels.
Purpose:
- To evaluate the safety and efficacy of deferred autotransfusion with the Cell-Saver system in elective cardiac surgery.
- To assess the rate of homologous blood transfusion requirement in patients undergoing this procedure.
- To determine the benefits of autotransfusion, including avoidance of transfusion-transmitted diseases and immunisation issues.
Summary:
- A review of 65 patients undergoing elective cardiac surgery demonstrated that deferred autotransfusion with the Cell-Saver system was well-tolerated.
- Only 10% of patients required homologous blood transfusions post-procedure.
- Normovolemic hemodilution offers advantages for patients with coronary artery disease.
Impact:
- Deferred autotransfusion with the Cell-Saver system is a safe and effective method for reducing homologous blood use in cardiac surgery.
- The technique offers economic benefits and mitigates risks associated with allogeneic blood transfusions.
- Wider implementation of this autotransfusion strategy is recommended for eligible cardiac surgery patients.